Bayer Bids To Be A Winner In Cell & Gene Therapy

Adopts Four-Pillar Strategy

 
• By Kevin Grogan

The last six weeks have seen the acquisition of AskBio, the launch of a dedicated cell and gene therapy unit and a CAR-T pact with Atara. Bayer is taking the space very seriously.

Marianne DeBacke
Business development boss Marianne De Backer • Source: Bayer

More from Gene Therapies

More from Advanced Therapies